PhaseBio Pharmaceuticals Inc
OTC:PHASQ

Watchlist Manager
PhaseBio Pharmaceuticals Inc Logo
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
Watchlist
Price: 0.0001 USD
Market Cap: 49.9 USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of PHASQ.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PHASQ Intrinsic Value
Not Available
Base Case Scenario
Compare PHASQ to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PHASQ?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
PhaseBio Pharmaceuticals Inc

Balance Sheet Decomposition
PhaseBio Pharmaceuticals Inc

Current Assets 48.8m
Cash & Short-Term Investments 41.8m
Other Current Assets 7m
Non-Current Assets 11.8m
PP&E 11.7m
Other Non-Current Assets 57k
Current Liabilities 27.9m
Accounts Payable 12.6m
Accrued Liabilities 8.4m
Other Current Liabilities 7m
Non-Current Liabilities 125.7m
Long-Term Debt 1.4m
Other Non-Current Liabilities 124.3m
Efficiency

Free Cash Flow Analysis
PhaseBio Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PhaseBio Pharmaceuticals Inc

Revenue
10.8m USD
Operating Expenses
-118.2m USD
Operating Income
-107.4m USD
Other Expenses
-23.7m USD
Net Income
-131.1m USD
Fundamental Scores

PHASQ Profitability Score
Profitability Due Diligence

PhaseBio Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Declining Operating Margin
hidden
Profitability
Score

PhaseBio Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PHASQ Solvency Score
Solvency Due Diligence

PhaseBio Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

PhaseBio Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHASQ Price Targets Summary
PhaseBio Pharmaceuticals Inc

There are no price targets for PHASQ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

PhaseBio Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PHASQ is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PHASQ Insider Trading
Buy and sell transactions by insiders